Segment Information

3 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Segment Information

(10)    Segment Information

The Company has five reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. Effective January 1, 2018, the Company no longer separately reports the activity in its transportation segment and transportation activities are reported within the other segments. Management believes this change will provide more accurate reporting of segment activity.

Prior period results for the affected segments have been retrospectively revised to reflect this change. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended March 31,
Sale of Product	2018		2017 (as adjusted)
Radiochemical Products	$	583,541	$	613,580
Cobalt Products		327,778		219,423
Nuclear Medicine Standards		1,002,113		808,406
Radiological Services		887,594		192,799
Fluorine Products		-		-
Total Segments		2,801,026		1,834,208
Corporate revenue		-		-
Total Consolidated	$	2,801,026	$	1,834,208
	Three months ended March 31,
Depreciation and Amortization	2018		2017 (as adjusted)
Radiochemical Products	$	5,014	$	1,609
Cobalt Products		4,043		9,770
Nuclear Medicine Standards		17,938		2,145
Radiological Services		12,039		12,438
Fluorine Products		26,095		26,095
Total Segments		65,130		52,057
Corporate depreciation and amortization		4,844		3,528
Total Consolidated	$	69,974	$	55,585
	Three months ended March 31,
Segment Income (Loss)	2018		2017 (as adjusted)
Radiochemical Products	$	40,520	$	118,155
Cobalt Products		184,792		120,061
Nuclear Medicine Standards		223,942		183,972
Radiological Services		402,012		90,918
Fluorine Products		(31,299)		(84,878)
Total Segments		819,966		428,228
Corporate loss		(785,562)		(1,214,494)
Net Income	$	34,404	$	(786,266)
	Three months ended March 31,
Expenditures for Segment Assets	2018		2017 (as adjusted)
Radiochemical Products	$	-	$	-
Cobalt Products		-		-
Nuclear Medicine Standards		18,148		(198)
Radiological Services		-		-
Fluorine Products		1,560		4,172
Total Segments		19,708		3,974
Corporate purchases		-		-
Total Consolidated	$	19,708	$	3,974
	March 31,		December 31,
Segment Assets	2018		2017 (as adjusted)
Radiochemical Products	$	320,491	$	282,971
Cobalt Products		2,291,891		1,813,356
Nuclear Medicine Standards		1,960,824		2,214,061
Radiological Services		150,173		198,437
Fluorine Products		5,675,321		5,702,159
Total Segments		10,398,700		10,210,984
Corporate assets		2,433,947		1,794,310
Total Consolidated	$	12,832,647	$	12,005,294